The Canadian Pari-Mutuel Agency (CPMA) is advising the Canadian horse racing industry of upcoming changes to the Elimination Guidelines. These changes are described below and will be implemented on March 7, 2022.
All Elimination Guidelines will remain the same for medications not listed below (For example, phenylbutazone).
The CPMA consulted with its Drug Advisory Committee on all of these changes.
Previously published versions of the Elimination Guidelines should not be relied on when making treatment decisions for a racehorse.
See the CPMA Elimination Guidelines. A PDF version is available for those who would like to print a copy.
The CPMA strongly recommends that you consult your veterinarian on any decision to administer supplements or medications to a horse.
Subscribe to the CPMA Email Subscription Service to receive industry notifications by email.
If you have any questions, please contact the CPMA at 1-800-268-8835 or aafc.cpmawebacpm.aac@agr.gc.ca.
From the Alcohol and Gaming Commission of Ontario
| Drug Name |
Current Elimination Guideline |
New Elimination Guideline |
| Atropine |
24h / 15 mg IV / single |
24h / 7 mg IV / single |
| Beclomethasone |
48h / 4 mg AER / single |
24h / 1 mg AER / single |
| Ciclesonide |
New |
48h / 2744 µg AER twice daily for 5 days, followed by 4116 µg AER once daily for 5 days |
| Dantrolene |
36h / 1 g PO / single |
48h / 1.5 g PO / single |
| 60h / 1 g PO / once daily x 5 days |
No change |
| Dembrexine |
72h / 150 mg PO / single |
Deleted |
| 72h / 150 mg PO / twice daily x 4 days |
No change |
| Dexamethasone |
New |
48h / 20 mg IM / single |
| 48h / 25 mg IV / single |
No change |
| 48h / 10 mg PO / once daily x 5 days |
No change |
| Flunixin |
48h / 500 mg PO / single |
No change |
| 48h / 500 mg IV / single |
No change |
| 72h / 500 mg IM / single |
Deleted |
| 72h / 500 mg IM / once daily x 3 days |
Deleted |
| 72h / 500 mg IM / once daily x 5 days |
Deleted |
| Isoflupredone |
48h / 24 mg IM / single |
72h / 20 mg IM / single |
| New |
7d / 10 mg IA / single |
| Meloxicam |
48h / 90 mg PO / single |
72h / 250 mg PO / single |
| 54h / 270 mg IV / single |
72h / 270 mg IV / single |
| Mepivacaine |
48h / 300 mg IA / single |
72h / 250 mg IA / single |
| 48h / 300 mg SC / single |
No change |
| Penicillin G procaine |
425h / 2 x 106 IU IM / single |
No change |
| 425h / 4 x 106 IU IM / single |
No change |
| 425h / 4 x 106 IU IM / once daily x 5 days |
No change |
| 425h / 6 x 106 IU IM / single |
No change |
| 60h / 4 x 106 IU PO / single |
Deleted |
| 48h / 0.2 x 106 IU TOP / single |
Deleted |
Salbutamol
(Albuterol) |
24 h / 0.8 mg AER / single |
24h / 0.3 mg AER / single |
| Salicylic acid |
24h / 11.7 g PO / single |
No change |
| 6h / 8.38 g TOP / single |
Deleted |
| 0h / 3.35 g TOP / single |
Deleted |
| Theophylline |
96h / 1.5 g IV / single |
No change |
| New |
72h / 4 g PO / single |
| Triamcinolone acetonide |
6d / 20 mg IA / single |
7d / 20 mg IA / single |
| New |
24h / 10 mg TOP / single |
| Trichlormethiazide |
24h / 100 mg PO / single |
48h / 100 mg PO / single |
| 24h / 200 mg PO / single |
48h / 200 mg PO / single |
| 24h / 100 mg IV / single |
48h / 100 mg IV / single |
| 36h / 100 mg IM / single |
48h / 100 mg IM / single |
| Xylazine |
24h / 500 mg IV / single |
48h / 500 mg IV / single |
|
Glossary |
| AER |
Aerosol |
| h |
Hours |
| IA |
Intra-articular |
| IM |
Intramuscular |
| IU |
International Units |
| IV |
Intravenous |
| PO |
Per os / Oral |
| SC |
Subcutaneous |
| TOP |
Topical |
USA
Canada
Australia
New Zealand
Europe
UK / IRE
